Pttg1/securin is required for the branching morphogenesis of the mammary gland and suppresses mammary tumorigenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 3, 2014, Pages 1008-1013

  Hatcher, Rashieda J ^a   Dong, Jie ^a   Liu, Shuang ^a   Bian, Guangxing ^b   Contreras, Alejandro ^a   Wang, Tao ^a   Hilsenbeck, Susan G ^a   Li, Yi ^a   Zhang, Pumin ^a,b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c BEIJING INSTITUTE OF LIFEOMICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYTOKERATIN 5; CYTOKERATIN 8; FIBROBLAST GROWTH FACTOR 2; GELATINASE A; SECURIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRANCHING MORPHOGENESIS; BREAST EPITHELIUM; BREAST TUMOR; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GRAFT RECIPIENT; IMMUNOHISTOCHEMISTRY; MAMMARY GLAND; MAMMARY TUMORIGENESIS; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; UPREGULATION;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHROMATIDS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASM PROTEINS; SECURIN; TIME FACTORS;

EID: 84892913199     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1318124111     Document Type: Article

References (40)

1. Pei L, Melmed S (1997) Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 11(4):433-441.
2. Puri R, Tousson A, Chen L, Kakar SS (2001) Molecular cloning of pituitary tumor transforming gene 1 from ovarian tumors and its expression in tumors. Cancer Lett 163(1):131-139.
3. Kakar SS (1999) Molecular cloning, genomic organization, and identification of the promoter for the human pituitary tumor transforming gene (PTTG). Gene 240(2):317-324.
4. Zhang X, et al. (1999) Structure, expression, and function of human pituitary tumortransforming gene (PTTG). Mol Endocrinol 13(1):156-166.
5. Boelaert K, et al. (2003) Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer. J Clin Endocrinol Metab 88(5):2341-2347.
6. Ramaswamy S, Ross KN, Lander ES, Golub TR (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33(1):49-54.
7. Hunter K, Welch DR, Liu ET (2003) Genetic background is an important determinant of metastatic potential. Nat Genet 34(1):23-24.
8. Abbud RA, et al. (2005) Early multipotential pituitary focal hyperplasia in the alphasubunit of glycoprotein hormone-driven pituitary tumor-transforming gene transgenic mice. Mol Endocrinol 19(5):1383-1391.
9. Chesnokova V, Kovacs K, Castro AV, Zonis S, Melmed S (2005) Pituitary hypoplasia in Pttg-/-mice is protective for Rb+/-pituitary tumorigenesis. Mol Endocrinol 19(9):2371-2379.
10. Tong Y, Eigler T (2009) Transcriptional targets for pituitary tumor-transforming gene-1. J Mol Endocrinol 43(5):179-185.
11. Zou H, McGarry TJ, Bernal T, Kirschner MW (1999) Identification of a vertebrate sisterchromatid separation inhibitor involved in transformation and tumorigenesis. Science 285(5426):418-422.
12. Uhlmann F (2003) Chromosome cohesion and separation: From men and molecules. Curr Biol 13(3):R104-R114.
13. Yamamoto A, Guacci V, Koshland D (1996) Pds1p, an inhibitor of anaphase in budding yeast, plays a critical role in the APC and checkpoint pathway (s). J Cell Biol 133(1):99-110.
14. Yamamoto A, Guacci V, Koshland D (1996) Pds1p is required for faithful execution of anaphase in the yeast, Saccharomyces cerevisiae. J Cell Biol 133(1):85-97.
15. Mei J, Huang X, Zhang P (2001) Securin is not required for cellular viability, but is required for normal growth of mouse embryonic fibroblasts. Curr Biol 11(15):1197-1201.
16. Stemmann O, Zou H, Gerber SA, Gygi SP, Kirschner MW (2001) Dual inhibition of sister chromatid separation at metaphase. Cell 107(6):715-726.
17. Huang X, Hatcher R, York JP, Zhang P (2005) Securin and separase phosphorylation act redundantly to maintain sister chromatid cohesion in mammalian cells. Mol Biol Cell 16(10):4725-4732.
18. Huang X, et al. (2008) Inhibitory phosphorylation of separase is essential for genome stability and viability of murine embryonic germ cells. PLoS Biol 6(1):e15.
19. Medina D (2010) Of mice and women: A short history of mouse mammary cancer research with an emphasis on the paradigms inspired by the transplantation method. Cold Spring Harb Perspect Biol 2(10):a004523.
20. Cardiff RD, Kenney N (2011) A compendium of the mouse mammary tumor biologist: From the initial observations in the house mouse to the development of genetically engineered mice. Cold Spring Harb Perspect Biol 3 (6).
21. Tong Y, Falk J (2009) Genome-wide analysis for protein-DNA interaction: ChIP-chip. Methods Mol Biol 590:235-251.
22. Tong Y, Tan Y, Zhou C, Melmed S (2007) Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition. Oncogene 26(38):5596-5605.
23. Fantl V, Stamp G, Andrews A, Rosewell I, Dickson C (1995) Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev 9(19):2364-2372.
24. Sicinski P, et al. (1995) Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82(4):621-630.
25. Bocchinfuso WP, Korach KS (1997) Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J Mammary Gland Biol Neoplasia 2(4):323-334.
26. Lydon JP, et al. (1995) Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9(18):2266-2278.
27. Brisken C, et al. (1998) A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci USA 95(9):5076-5081.
28. Fata JE, Werb Z, Bissell MJ (2004) Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res 6(1):1-11.
29. Wiseman BS, et al. (2003) Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol 162(6):1123-1133.
30. Hauf S, Waizenegger IC, Peters JM (2001) Cohesin cleavage by separase required for anaphase and cytokinesis in human cells. Science 293(5533):1320-1323.
31. Bissell MJ, Polyak K, Rosen JM (2011) The Mammary Gland as an Experimental Model. Cold Spring Harbor Perspectives in Biology (Cold Spring Harbor Laboratory Press, Plainview, NY).
32. Brisken C (2002) Hormonal control of alveolar development and its implications for breast carcinogenesis. J Mammary Gland Biol Neoplasia 7(1):39-48.
33. Brisken C, et al. (1999) Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol 210(1):96-106.
34. Mallepell S, Krust A, Chambon P, Brisken C (2006) Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci USA 103(7):2196-2201.
35. Oakes SR, Rogers RL, Naylor MJ, Ormandy CJ (2008) Prolactin regulation of mammary gland development. J Mammary Gland Biol Neoplasia 13(1):13-28.
36. Soyal S, et al. (2002) Progesterone's role in mammary gland development and tumorigenesis as disclosed by experimental mouse genetics. Breast Cancer Res 4(5):191-196.
37. Babu JR, et al. (2003) Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J Cell Biol 160(3):341-353.
38. Baker DJ, et al. (2004) BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet 36(7):744-749.
39. Li M, Fang X, Wei Z, York JP, Zhang P (2009) Loss of spindle assembly checkpointmediated inhibition of Cdc20 promotes tumorigenesis in mice. J Cell Biol 185(6):983-994.
40. Dai W, et al. (2004) Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Res 64(2):440-445.